NEW YORK, Sept. 17 (GenomeWeb News) - Stratagene said yesterday that a patent infringement lawsuit Third Wave filed against it on Wednesday is without  merit.

"We are surprised that Third Wave would file this lawsuit before discussing with us the differences in the two companies' technologies," Joseph Sorge, Stratagene's chairman and CEO, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.